You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0088 Cyclic citrullinated peptides from the sequence of modified vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – prognosis, predictors and outcome
FRI0088 Cyclic citrullinated peptides from the sequence of modified vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014300
Mar 2014400
Apr 2014100
May 2014100
Jul 2014100
Sep 2014801
Oct 2014300
Nov 2014400
Dec 2014200
Mar 2015200
Apr 2015300
May 2015100
Jun 2015200
Jul 2015400
Aug 2015400
Sep 20151000
Nov 2015600
Dec 2015800
Jan 2016100
Feb 20161302
Mar 2016100
Apr 2016100
May 2016200
Jun 20161000
Jul 2016301
Aug 2016400
Sep 2016200
Oct 2016300
Nov 2016700
Dec 2016300
Jan 2017300
Feb 2017100
Mar 2017300
Apr 20171200
May 2017500
Jun 2017200
Aug 2017801
Sep 2017800
Oct 20171800
Nov 20171000
Dec 2017400
Jan 20182401
Feb 2018200
Mar 2018800
Apr 2018800
May 2018800
Jun 2018400
Jul 2018800
Aug 2018400
Sep 2018400
Oct 2018400
Nov 2018200
Jan 2019100
Feb 2019200
Apr 2019200
Jul 2019400
Aug 2019200
Nov 2019203
Feb 2020200
Apr 2020200
Jun 2020600
Jul 2020600
Aug 2020600
Sep 20201601
Oct 2020200
Nov 2020800
Dec 2020600
Jan 2021202
Apr 2021800
Sep 2021100
Oct 2021600
Nov 2021801
Dec 20211000
Jan 2022800
Feb 20221000
Mar 2022800
Apr 2022500
May 20221500
Jun 2022400
Jul 20221400
Aug 20221001
Sep 2022400
Oct 2022800
Nov 20221000
Dec 2022800
Jan 2023200
Feb 2023800
Mar 2023600
Apr 2023400
May 2023600
Jun 2023400
Jul 2023200
Aug 2023400
Sep 2023700
Oct 20232401
Dec 2023400
Jan 2024700
Feb 2024200
Mar 2024200
Total555015